Sarah Ftouni

1.9k total citations
11 papers, 231 citations indexed

About

Sarah Ftouni is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sarah Ftouni has authored 11 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Sarah Ftouni's work include Cancer Genomics and Diagnostics (8 papers), Acute Myeloid Leukemia Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Sarah Ftouni is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Acute Myeloid Leukemia Research (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Sarah Ftouni collaborates with scholars based in Australia and United States. Sarah Ftouni's co-authors include Sarah‐Jane Dawson, Stephen Q. Wong, Mark A. Dawson, Danny Rischin, William C. Hahn, Elizabeth Loehrer, George Au‐Yeung, Scott L. Carter, Thomas J. Mitchell and Linda Mileshkin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Sarah Ftouni

10 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Ftouni Australia 5 113 100 94 65 36 11 231
James B. Studd United Kingdom 7 256 2.3× 77 0.8× 92 1.0× 22 0.3× 39 1.1× 9 362
Paola Francica Switzerland 10 158 1.4× 47 0.5× 124 1.3× 57 0.9× 21 0.6× 14 249
Takako Yokomizo‐Nakano Japan 7 137 1.2× 67 0.7× 68 0.7× 16 0.2× 14 0.4× 18 219
G Selvaluxmy India 7 176 1.6× 88 0.9× 79 0.8× 42 0.6× 20 0.6× 11 274
Chelsea Jenkins United States 4 114 1.0× 60 0.6× 105 1.1× 118 1.8× 16 0.4× 5 216
Gavin D. Garland United Kingdom 6 152 1.3× 42 0.4× 70 0.7× 53 0.8× 64 1.8× 9 256
Collin C. Collins United States 7 242 2.1× 121 1.2× 73 0.8× 53 0.8× 36 1.0× 11 356
Mary McGrath United States 10 183 1.6× 110 1.1× 34 0.4× 36 0.6× 19 0.5× 19 284
Lisa Thelen Germany 5 232 2.1× 59 0.6× 139 1.5× 22 0.3× 39 1.1× 5 290
Simona Frezzini Italy 6 113 1.0× 89 0.9× 93 1.0× 42 0.6× 16 0.4× 8 231

Countries citing papers authored by Sarah Ftouni

Since Specialization
Citations

This map shows the geographic impact of Sarah Ftouni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Ftouni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Ftouni more than expected).

Fields of papers citing papers by Sarah Ftouni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Ftouni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Ftouni. The network helps show where Sarah Ftouni may publish in the future.

Co-authorship network of co-authors of Sarah Ftouni

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Ftouni. A scholar is included among the top collaborators of Sarah Ftouni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Ftouni. Sarah Ftouni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tiong, Ing Soo, Tamia Nguyen, Chong Chyn Chua, et al.. (2025). Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer. Blood Advances. 9(17). 4391–4395.
2.
Hollizeck, Sebastian, Stephen Q. Wong, Sarah Ftouni, et al.. (2024). Unravelling mutational signatures with plasma circulating tumour DNA. Nature Communications. 15(1). 9876–9876. 1 indexed citations
3.
Tiong, Ing Soo, Tamia Nguyen, Charis E. Teh, et al.. (2023). BAX Mutated Clonal Hematopoiesis Arises Following Treatment with the BCL2 Inhibitor Class of Therapeutics across a Range of Hematological and Non-Hematological Neoplasms. Blood. 142(Supplement 1). 2688–2688. 3 indexed citations
4.
Savas, Peter, Stephen J. Luen, Elizabeth F. Blackley, et al.. (2022). Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study. Cancer Discovery. 12(9). 2058–2073. 38 indexed citations
5.
Zozaya‐Valdés, Enrique, Stephen Q. Wong, Jeanette Raleigh, et al.. (2021). Detection of cell-free microbial DNA using a contaminant-controlled analysis framework. Genome biology. 22(1). 187–187. 27 indexed citations
6.
Weng, Chen-Fang, Maria João Silva, Miriam M. Yeung, et al.. (2020). Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study. PLoS Medicine. 17(10). e1003363–e1003363. 24 indexed citations
7.
Weng, Chen-Fang, Miriam M. Yeung, Sarah Ftouni, et al.. (2019). Prospective testing of circulating tumour DNA in metastatic breast cancer facilitates clinical trial enrollment and precision oncology. Annals of Oncology. 30. v30–v30. 2 indexed citations
8.
Dawson, Sarah‐Jane, Lironne Wein, Maria João Silva, et al.. (2018). Plasma and tumor genomic correlates of response to BYL719 in PI3KCA mutated metastatic ER-positive breast cancer (ER+/HER2- BC).. Journal of Clinical Oncology. 36(15_suppl). 1055–1055. 3 indexed citations
9.
Yeh, Paul, Michael Dickinson, Sarah Ftouni, et al.. (2017). Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes. Blood. 129(12). 1685–1690. 42 indexed citations
10.
Sandhu, Shahneen, Stephen Q. Wong, Ismael A. Vergara, et al.. (2016). Circulating tumor DNA (ctDNA) to track responses and to capture the genomic heterogeneity of metastatic melanoma.. Journal of Clinical Oncology. 34(15_suppl). 9582–9582. 1 indexed citations
11.
Etemadmoghadam, Dariush, George Au‐Yeung, Meaghan Wall, et al.. (2013). Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer. Clinical Cancer Research. 19(21). 5960–5971. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James B. Studd Breakdown of academic impact, for papers by Paola Francica Breakdown of academic impact, for papers by Takako Yokomizo‐Nakano Breakdown of academic impact, for papers by G Selvaluxmy Breakdown of academic impact, for papers by Chelsea Jenkins Breakdown of academic impact, for papers by Gavin D. Garland Breakdown of academic impact, for papers by Collin C. Collins Breakdown of academic impact, for papers by Mary McGrath Breakdown of academic impact, for papers by Lisa Thelen Breakdown of academic impact, for papers by Simona Frezzini
Rankless by CCL
2026